Viewing Study NCT06215651


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-02-02 @ 8:17 AM
Study NCT ID: NCT06215651
Status: RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma
Sponsor: Peking Union Medical College Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cadonilimab and Lenvatinib View
Keywords: